Viridian Therapeutics (VRDN) Earnings (2013 - 2026)
Viridian Therapeutics (VRDN) earnings from Jun 30, 2013 to Mar 31, 2026. The TTM Viridian Therapeutics (VRDN) earnings is -$361M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Viridian Therapeutics (VRDN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +16.95% |
| 3 Years TTM | +27.91% |
| 5 Years TTM | +24.38% |
| 10 Years TTM | +41.20% |
| All Time TTM | +44.07% |
Annual Earnings change of Viridian Therapeutics (VRDN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$105M | -69.38% |
| 2025 | -$343M | +26.91% |
| 2024 | -$270M | +13.55% |
| 2023 | -$238M | +83.05% |
| 2022 | -$130M | +63.54% |
| 2021 | -$79M | -28.27% |
| 2020 | -$111M | +164.41% |
| 2019 | -$42M | +28.04% |
| 2018 | -$33M | +23.35% |
| 2017 | -$27M | +53.50% |
| 2016 | -$17M | +52.43% |
| 2015 | -$11M | +43.60% |
| 2014 | -$7.89M | +265.28% |
| 2013 | -$2.16M | N/A |
Comparison Viridian Therapeutics (VRDN) five years earnings CAGR with competitors
Viridian Therapeutics (VRDN) five years earnings CAGR is 24.38%.